Furious Booming Blue Raspberry
AI Sports Nutrition Furious Booming Blue Raspberry is an 'Other Combinations' supplement, typically used for joint and bone support or as a pre-workout, containing 9 ingredients. This product received an N+ Score of 60, which corresponds to a D grade, indicating an average quality tier. It features CarnoSyn at a clinically studied dose of 2000 mg and Taurine at 500 mg, also considered a clinical dose for certain applications. However, key electrolytes like Calcium (72.5 mg), Magnesium (35 mg), and Potassium (131 mg) are underdosed compared to general daily recommendations. This supplement may appeal to those seeking specific amino acids like CarnoSyn and Taurine, with transparent ingredient listing.
About This Product
Furious Booming Blue Raspberry by AI Sports Nutrition is a joint & bone supplement containing 9 active ingredients. It has earned an N+ Score of 60/100 (Grade D).
Notable clinical-dose ingredients include CarnoSyn, Taurine.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +2 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (9 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calcium | 72.500 mg | Under |
| Magnesium | 35.000 mg | Under |
| Sodium | 97.500 mg | N/A |
| Potassium | 131.000 mg | Under |
| CarnoSyn | 2000.000 mg | High |
| Electrolyte Blend | 1000.000 mg | N/A |
| Taurine | 500.000 mg | High |
| Grape seed extract | 300.000 mg | N/A |
| Instigator Complex | 940.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.
